$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc ([...
$Monopar Therapeutics (MNPR.US)$ Monopar Therapeutics Inc (MNPR – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Soumit Roy from JonesTrading upgraded the rating on the stock to a Buy and gave it a $2.00 price target.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment